Stimuli‐Responsive Polymeric Nanoparticles for Nanomedicine

Abstract

Nature continues to be the ultimate in nanotechnology, where polymeric nanometer-scale architectures play a central role in biological systems. Inspired by the way nature forms functional supramolecular assemblies, researchers are trying to make nanostructures and to incorporate these into macrostructures as nature does. Recent advances and progress in nanoscience have demonstrated the great potential that nanomaterials have for applications in healthcare. In the realm of drug delivery, nanomaterials have been used in vivo to protect the drug entity in the systemic circulation, ensuring reproducible absorption of bioactive molecules that do not naturally penetrate biological barriers, restricting drug access to specific target sites. Several building blocks have been used in the formulation of nanoparticles. Thus, stability, drug release, and targeting can be tailored by surface modification. Herein the state of the art of stimuli-responsive polymeric nanoparticles are reviewed. Such systems are able to control drug release by reacting to naturally occurring or external applied stimuli. Special attention is paid to the design and nanoparticle formulation of these so-called smart drug-delivery systems. Future strategies for further developments of a promising controlled drug delivery responsive system are also outlined.

Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy

“…First, they hold high stability and good biocompatibility both in vitro and in vivo , and can solubilize a wide range of poorly soluble drugs. Polymeric nanoparticles are commonly prepared from natural polymers (such as chitosan) or synthetic biocompatible polymers [such as poly-lactic-co-glycolic acid (PLGA)], while liposomes, analogs of biological membranes, have always been regarded as one of the most biocompatible vehicles for drug delivery (Colson and Grinstaff, 2012; Hadinoto et al, 2013; Mandal et al, 2013; Crucho, 2015). In addition, polyethylene glycol (PEG) is usually conjugated to the polymer nanoparticles to enhance the immune-compatibility.…”

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials

“…PEG and PEI are also functionalized through amine, carboxylic acids or maleimide groups to peptides, antibodies or any other ligands for active targeting [71,157,158]. Several liposomal formulations for cancer therapy have been approved by the Food and Drug Administration (FDA) [159,160], and have shown promising results in preclinical and clinical studies for drug delivery [150,161,162]. One example is a clinical trial phase I study for the delivery of a siRNA-containing liposomal formulation against EphA2 (Ephrin type-A receptor 2) to solid tumors (NCT01591356) [163].…”

Synthesis and Cellular Internalization of Spindle Hematite/Polymer Hybrid Nanoparticles

“…[1][2][3][4][5] A pioneering study by Savic et al reported on spherical micelles self-assembled by fluorescently labeled poly(ethylene oxide)-b-poly(ε-caprolactone) (PEO-b-PCL) and investigated their intracellular distribution, providing a biological basis for polymeric nanoparticles as intracellular drug delivery vehicles. 6 Since then, much of the research has focused on the investigation of spherical nanoparticles.…”